Home
/
BIO-RAD LABORATORIES, INC.
/
Financials
/
Quarterly
BIO-RAD LABORATORIES, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BIO-RAD LABORATORIES, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$653.00M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$651.60M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$585.40M
May 1, 2025
Q3
2025
Sep 30, 2024
$649.70M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$638.50M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$610.80M
May 1, 2025
Q3
2024
Sep 30, 2023
$632.12M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$681.11M
Aug 2, 2024
Q1
2024
Mar 31, 2023
$676.84M
May 8, 2024
Q3
2023
Sep 30, 2022
$680.80M
Oct 27, 2023
Q2
2023
Jun 30, 2022
$691.10M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$700.06M
May 5, 2023
Q3
2022
Sep 30, 2021
$747.05M
Oct 28, 2022
Q2
2022
Jun 30, 2021
$715.93M
Jul 29, 2022
Q1
2022
Mar 31, 2021
$726.80M
Apr 29, 2022
Q3
2021
Sep 30, 2020
$647.26M
Oct 29, 2021
Q2
2021
Jun 30, 2020
$536.88M
Jul 30, 2021
Q1
2021
Mar 31, 2020
$571.64M
Apr 30, 2021
Q3
2020
Sep 30, 2019
$560.63M
Oct 30, 2020
Q2
2020
Jun 30, 2019
$572.62M
Jul 31, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$551.52M
May 10, 2018
Q3
2017
Sep 30, 2017
$535.00M
Nov 9, 2017
Q2
2017
Jun 30, 2017
$504.67M
Aug 7, 2017
Q1
2018
Mar 31, 2017
$500.05M
May 10, 2018
Q3
2017
Sep 30, 2016
$508.75M
Nov 9, 2017
Q2
2017
Jun 30, 2016
$516.78M
Aug 7, 2017
Q1
2017
Mar 31, 2016
$471.20M
May 9, 2017
Q3
2016
Sep 30, 2015
$469.96M
Nov 2, 2016
Q2
2016
Jun 30, 2015
$506.10M
Aug 5, 2016
Q1
2016
Mar 31, 2015
$472.82M
May 6, 2016
Q3
2015
Sep 30, 2014
$530.64M
Nov 5, 2015
Q2
2015
Jun 30, 2014
$536.83M
Aug 7, 2015
Q1
2015
Mar 31, 2014
$509.34M
May 6, 2015
Q3
2014
Sep 30, 2013
$505.07M
Nov 7, 2014
Q2
2014
Jun 30, 2013
$525.32M
Aug 6, 2014
Q1
2014
Mar 31, 2013
$499.67M
May 8, 2014
Q3
2013
Sep 30, 2012
$498.70M
Nov 12, 2013
Q2
2013
Jun 30, 2012
$510.42M
Aug 8, 2013
Q1
2013
Mar 31, 2012
$486.28M
May 10, 2013
Q3
2012
Sep 30, 2011
$516.51M
Nov 8, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($341.90M)
Oct 29, 2025
Q3
2025
Jun 30, 2025
$317.80M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$317.80M
Jul 31, 2025
Q2
2025
Mar 31, 2025
$64.00M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$64.00M
May 1, 2025
Q3
2025
Mar 31, 2025
$64.00M
Oct 29, 2025
Q3
2025
Sep 30, 2024
$653.20M
Oct 29, 2025
Q3
2025
Jun 30, 2024
($2.17B)
Oct 29, 2025
Q2
2025
Jun 30, 2024
($2.17B)
Jul 31, 2025
Q1
2025
Mar 31, 2024
$383.90M
May 1, 2025
Q2
2025
Mar 31, 2024
$383.90M
Jul 31, 2025
Q3
2025
Mar 31, 2024
$383.90M
Oct 29, 2025
Q3
2024
Sep 30, 2023
$106.26M
Oct 31, 2024
Q3
2024
Jun 30, 2023
($1.16B)
Oct 31, 2024
Q2
2024
Jun 30, 2023
($1.16B)
Aug 2, 2024
Q2
2024
Mar 31, 2023
$68.96M
Aug 2, 2024
Q3
2024
Mar 31, 2023
$68.96M
Oct 31, 2024
Q1
2024
Mar 31, 2023
$68.96M
May 8, 2024
Q3
2023
Sep 30, 2022
($162.81M)
Oct 27, 2023
Q3
2023
Jun 30, 2022
($925.11M)
Oct 27, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$65.30M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$77.10M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$23.70M
May 1, 2025
Q3
2025
Sep 30, 2024
$64.50M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$101.50M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$44.60M
May 1, 2025
Q3
2024
Sep 30, 2023
$90.95M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$89.62M
Aug 2, 2024
Q1
2024
Mar 31, 2023
$61.91M
May 8, 2024
Q3
2023
Sep 30, 2022
$94.65M
Oct 27, 2023
Q2
2023
Jun 30, 2022
$122.89M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$146.41M
May 5, 2023
Q3
2022
Sep 30, 2021
$156.80M
Oct 28, 2022
Q2
2022
Jun 30, 2021
$124.78M
Jul 29, 2022
Q1
2022
Mar 31, 2021
$100.86M
Apr 29, 2022
Q3
2021
Sep 30, 2020
$109.60M
Oct 29, 2021
Q2
2021
Jun 30, 2020
$51.74M
Jul 30, 2021
Q1
2021
Mar 31, 2020
$74.37M
Apr 30, 2021
Q3
2020
Sep 30, 2019
$57.46M
Oct 30, 2020
Q2
2020
Jun 30, 2019
$56.39M
Jul 31, 2020